Immunity for Health

IfH Symposium: Innovations in Antibody-Based Biologics

11 Jun 2026 | Landmark Building, UZ Brussels, Belgium

Biocytogen

Biotech / Medtech / Start-up

biocytogen.com/Waltham, United States
8 profile visits

About

Biocytogen is a global biotech company that drives the discovery of fully human monoclonal, bispecific, multispecific, ADC, VHH, and TCR-mimic antibodies across 1,000+ druggable targets, providing 1M+ antibody sequences through RenBiologics™. Biocytogen pioneers drug target knock-in humanized models and offers 4,000+ models via BioMice™, along with in vivo, ex vivo, and in vitro pharmacology and custom gene-editing services.

HEALTH SECTOR

Human health

RESEARCH AND DEVELOPMENT

Preclinical researchCell and Gene therapy

THERAPEUTIC AREAS

OncologyImmunologyAutoimmune disordersRespiratory diseasesAllergiesCardiovascular diseasesNeurodegenerative diseases

Representatives

Business Development Manager

Biocytogen